After two years of trial, Ozempic, Mounjaro, and Wygovy became just a few of the leading prescriptions that our nation is scrambling to fill for the overweight and diabetic community.  This seems to be the easy and quickest way to shred dozens to hundreds of pounds….so what could be wrong with that?   Unfortunately, quick and easy does not come without a price.  The price is two-fold: 1) the pharmaceutical companies are barely able to keep up with the demand, and 2) the drug-related medical complications are starting to pile up. 

Topics for legal concern:

 The American Diabetic Assn and American Medical Assn clearly define the treatment algorithms for diabetic complications.  However, this new breed of diabetic treatment modalities have put a twist on what was previously well-known standard of care.   New complications that are underdiagnosed or missed altogether include: 

• Undiagnosed Euglycemic diabetic ketoacidosis (DKA)

• Secondary Pancreatitis (initial studies did not include history of prior pancreatitis)

• Severe retinopathy and blindness warning prior to administration

• Drug-associated intestinal blockage (recent black-box warning)

Future Concerns with these Drugs:

• Drug-related deaths 

• Drug-related malignancies

• Drug-related permanent injury  

What the UPvision Consulting, LLC team can do for you:

Our team can review documentation, including medical and nursing documentation, timing of treatments, and missing interventions based upon the Standard of Care outlined by ADA https://www.uptodate.com and AMA https://www.ncbi.nlm.nih.gov or  https://journalofethics.ama-assn.org guidelines.  We can sort thru the data to determine merit,  develop the timeline, and assist through the medical components of any potential case.

Reach Out to Experts at UPvision Consulting:

As newer generations of diabetic medicines emerge and complications increase with time, I suspect we may discover irreversible links to a host of complications not yet unveiled.  Researchers agree that caution must be given in these early years of treatment, as there is still much research collection that is yet to be done. Visit our website or call us directly to schedule a consult today for any concerns or review of any case that may be related to any concern for malpractice or personal injury.